Asset Acquisitions - Acquisition of Emerald Health Therapeutics, Inc., Narrative (Details) - Emerald Health Therapeutics Inc |
Nov. 10, 2022
USD ($)
shares
|
|---|---|
| Asset Acquisition [Line Items] | |
| Exchange ratio | 1.95 |
| Net assets acquired, fair value | $ 15,045,412 |
| Qualifying asset | $ 1,536,275 |
| Equity interest issued or issuable (in shares) | shares | 1,665,083 |
| X | ||||||||||
- Definition Asset Acquisition, Assets Acquired and Liabilities Assumed, Gross No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Exchange Ratio No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Qualifying Asset No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|